Specializing in Cross-Border Private Equity and Advisory

Bridge Point Capital is a New York-based private equity firm that specializes in U.S/China cross-border investments. We aim to identify well-managed, high quality Western companies with advanced technology or systems to disrupt the Chinese healthcare market.

BUSINESSES

PRIVATE EQUITY

Bridge Point Private Equity focuses on investing in late-stage healthcare companies that will benefit from penetrating the vast Chinese healthcare market.

CO-INVESTMENT PLATFORM

Bridge Point Co-Investment Platform creates value through investing in exclusive early-stage private companies in the healthcare sector.

FINANCIAL ADVISORY

Bridge Point Advisory specializes in the commercialization of Western healthcare technology and products in the rapidly growing Chinese market.

Proven Platform

China Cross-Border Specialists


Our partners and advisors average over two decades of direct experience investing and operating in China. We aim to leverage our expertise in cross-border investing, deal-structuring and operational execution to achieve help our portfolio companies penetrate the Chinese market.

Partnerships and Alliances


Our team has built a vast network of strategic industry contacts both in China and the U.S. Additionally, we have planned partnerships with large healthcare institutions including CITIC Medical & Health, China’s leading state-owned healthcare investment firm.

Focus on Innovation, Value and Scalability


Our focus is on investing in innovative and rapidly scalable companies that have aspirations and execution capability to penetrate China’s healthcare market. We will actively assist portfolio companies to bridge the gap between Chinese and U.S healthcare markets.